Parkinson’s disease mouse models in translational research

被引:0
|
作者
Paul M. A. Antony
Nico J. Diederich
Rudi Balling
机构
[1] University of Luxembourg,Luxembourg Centre for Systems Biomedicine (LCSB)
[2] Centre Hospitalier de Luxembourg,Department of Neuroscience
来源
Mammalian Genome | 2011年 / 22卷
关键词
Bacterial Artificial Chromosome; MPTP; Translational Research; Nigrostriatal Dopaminergic Neuron; Nonmotor Symptom;
D O I
暂无
中图分类号
学科分类号
摘要
Animal models with high predictive power are a prerequisite for translational research. The closer the similarity of a model to Parkinson’s disease (PD), the higher is the predictive value for clinical trials. An ideal PD model should present behavioral signs and pathology that resemble the human disease. The increasing understanding of PD stratification and etiology, however, complicates the choice of adequate animal models for preclinical studies. An ultimate mouse model, relevant to address all PD-related questions, is yet to be developed. However, many of the existing models are useful in answering specific questions. An appropriate model should be chosen after considering both the context of the research and the model properties. This review addresses the validity, strengths, and limitations of current PD mouse models for translational research.
引用
收藏
页码:401 / 419
页数:18
相关论文
共 50 条
  • [41] Mouse models of Alzheimer?s disease for preclinical research
    Watamura, Naoto
    Sato, Kaori
    Saido, Takaomi C.
    NEUROCHEMISTRY INTERNATIONAL, 2022, 158
  • [42] Current animal models of Alzheimer's disease: challenges in translational research
    Cuadrado-Tejedor, Mar
    Garcia-Osta, Ana
    FRONTIERS IN NEUROLOGY, 2014, 5
  • [43] Parkinson's disease rodent models: Are they suitable for DBS research?
    Merino Ruiz, Miguel Cesar
    Guimaraes, Rayanne Poletti
    Mortari, Marcia Renata
    JOURNAL OF NEUROSCIENCE METHODS, 2022, 380
  • [44] Translational research of sensory systems in models of aging and Alzheimer's disease
    Tapias, Baldo
    Gimenez-Llort, Lydia
    Lista, Virginia Torres
    Lopez-Pousa, Secundi
    INTERNATIONAL PSYCHOGERIATRICS, 2019, 31 : 39 - 40
  • [45] Modeling Nonmotor Symptoms of Parkinson's Disease in Genetic Mouse Models
    Fleming, Sheila M.
    Chesselet, Marie-Francoise
    BASAL GANGLIA IX, 2009, 58 : 483 - 491
  • [46] Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease
    Pain, Stephanie
    Gochard, Alice
    Bodard, Sylvie
    Gulhan, Zuhal
    Prunier-Aesch, Caroline
    Chalon, Sylvie
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2013, 65 (05) : 689 - 694
  • [47] Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson's disease
    Pang, Meijun
    Peng, Rui
    Wang, Yiwen
    Zhu, Yi
    Wang, Peng
    Moussian, Bernard
    Su, Yanfang
    Liu, Xiuyun
    Ming, Dong
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [48] A new generation of mouse models of cancer for translational research
    Abate-Shen, Cory
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5274 - 5276
  • [49] Experimental mouse models for translational human cancer research
    Zhou, Yinxi
    Xia, Jinghua
    Xu, Shuonan
    She, Tao
    Zhang, Yanning
    Sun, Ying
    Wen, Miaomiao
    Jiang, Tao
    Xiong, Yanlu
    Lei, Jie
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Animal Models for Parkinson's Disease Research: Trends in the 2000s
    Kin, Kyohei
    Yasuhara, Takao
    Kameda, Masahiro
    Date, Isao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)